Showing results (211-220 of 241) with videos related to
Sort By:
Pageof 25
Science Translational Medicine|January 27, 2017
CD99 is a therapeutic target on disease stem cells in myeloid malignanciesStephen S Chung, William S Eng, Wenhuo Hu, et al.Journal of Oncology Practice|December 12, 2018
1-2-3 Project: A Quality Improvement Initiative to Normalize and Systematize Palliative Care for All Patients With Cancer in the Outpatient Clinic SettingAnjali V Desai, Virginia M Klimek, Kimberly Chow, et al.Resuscitation|April 18, 2020
A cross-sectional investigation of communication in Do-Not-Resuscitate orders in Dutch hospitalsM Schluep, S E Hoeks, H Endeman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
T-cell responses against tyrosinase 368-376(370D) peptide in HLA*A0201+ melanoma patients: randomized trial comparing incomplete Freund's adjuvant, granulocyte macrophage colony-stimulating factor, and QS-21 as immunological adjuvantsSusanne G Schaed, Virginia M Klimek, Katherine S Panageas, et al.Bone Marrow Transplantation|August 24, 2018
End-of-life care for older AML patients relapsing after allogeneic stem cell transplant at a dedicated cancer centerRichard J Lin, Theresa A Elko, Miguel-Angel Perales, et al.The New England Journal of Medicine|November 9, 2012
Progression of RAS-mutant leukemia during RAF inhibitor treatmentMargaret K Callahan, Raajit Rampal, James J Harding, et al.Cell Transplantation|June 9, 2009
Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human isletsJames D Johnson, Ziliang Ao, Peter Ao, et al.The Journal of Clinical Endocrinology and Metabolism|April 4, 2017
Measurement of Pro-Islet Amyloid Polypeptide (1-48) in Diabetes and Islet TransplantsJaques A Courtade, Agnieszka M Klimek-Abercrombie, Yi-Chun Chen, et al.Journal of Critical Care|December 2, 2021
In-depth assessment of health-related quality of life after in-hospital cardiac arrestM Schluep, H Endeman, B Y Gravesteijn, et al.British Journal of Haematology|January 10, 2006
Doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective well tolerated initial therapy for multiple myelomaHani Hassoun, Lilian Reich, Virginia M Klimek, et al.Pageof 25